NO20023875L - Stabilt nasalt, oralt eller sublingualt anvendbart preparat - Google Patents

Stabilt nasalt, oralt eller sublingualt anvendbart preparat

Info

Publication number: NO20023875L
Authority: NO; Norway
Prior art keywords: sublingually; oral; stable; preparation; usable preparation
Prior art date: 2000-02-16

Application number

NO20023875A

Other languages

English (en)

Norwegian (no)

Other versions

NO20023875D0 (no

Inventor

Helmut Scheidl

Gerhard Hantich

Ernst Hesse

Thomas Zapf

Original Assignee

Gebro Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-16

Filing date

2002-08-15

Publication date

2002-10-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3669975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023875(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-08-15 Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh

2002-08-15 Publication of NO20023875D0 publication Critical patent/NO20023875D0/no

2002-10-11 Publication of NO20023875L publication Critical patent/NO20023875L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Physiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Nutrition Science (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20023875A 2000-02-16 2002-08-15 Stabilt nasalt, oralt eller sublingualt anvendbart preparat NO20023875L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0023300A AT409081B (de)	2000-02-16	2000-02-16	Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
PCT/AT2001/000007 WO2001060394A1 (fr)	2000-02-16	2001-01-10	Preparation pharmaceutique stable, pouvant etre utilisee par voie nasale, orale ou sublinguale

Publications (2)

Publication Number	Publication Date
NO20023875D0 NO20023875D0 (no)	2002-08-15
NO20023875L true NO20023875L (no)	2002-10-11

Family

ID=3669975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20023875A NO20023875L (no)	2000-02-16	2002-08-15	Stabilt nasalt, oralt eller sublingualt anvendbart preparat

Country Status (20)

Country	Link
US (1)	US20030119728A1 (fr)
EP (1)	EP1255557B1 (fr)
JP (1)	JP2003529562A (fr)
AT (2)	AT409081B (fr)
AU (1)	AU771251B2 (fr)
CA (1)	CA2399822A1 (fr)
CZ (1)	CZ20022686A3 (fr)
DE (1)	DE50100958D1 (fr)
DK (1)	DK1255557T3 (fr)
ES (1)	ES2210121T3 (fr)
HU (1)	HU229961B1 (fr)
NO (1)	NO20023875L (fr)
NZ (1)	NZ520396A (fr)
PL (1)	PL357132A1 (fr)
PT (1)	PT1255557E (fr)
SI (1)	SI21026B (fr)
SK (1)	SK285374B6 (fr)
TR (1)	TR200400234T4 (fr)
WO (1)	WO2001060394A1 (fr)
ZA (1)	ZA200205868B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
AU2003269747A1 (en) *	2002-05-15	2003-12-02	Sun Pharmaceutical Industries Limited	A stable aqueous composition of a peptide
AT413078B (de) *	2002-10-10	2005-11-15	Gebro Pharma Gmbh	Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
US7094545B2 (en)	2003-04-30	2006-08-22	Ferring Bv	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE301990T1 (de)	2003-07-25	2005-09-15	Ferring Bv	Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
ES2260563T3 (es) *	2003-11-13	2006-11-01	Ferring B.V.	Paquete de blister y forma farmaceutica solida para ello.
US7018653B2 (en)	2003-12-29	2006-03-28	Ferring B.V.	Method for preparing solid dosage form of desmopressin
JP5079257B2 (ja) *	2005-05-16	2012-11-21	株式会社三和化学研究所	Ｂｕｒｋｈｏｌｄｅｒｉａｃｅｐａｃｉａに対する保存剤
SE0600482L (sv) *	2006-03-02	2006-11-14	Ferring Int Ct Sa	Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) *	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
CA2988753A1 (fr)	2007-08-06	2009-02-12	Serenity Pharmaceuticals, Llc	Procedes et dispositifs pour l'administration de medicament desmopressine
LT3085381T (lt) *	2008-05-21	2018-06-11	Ferring B.V.	Burnoje disperguojamas desmopresinas, skirtas naktinio šlapinimosi netrikdomo miego periodo pailginimui
US11963995B2 (en)	2008-05-21	2024-04-23	Ferring B.V.	Methods comprising desmopressin
US20100286045A1 (en)	2008-05-21	2010-11-11	Bjarke Mirner Klein	Methods comprising desmopressin
JO3400B1 (ar)	2010-09-30	2019-10-20	Ferring Bv	مركب صيدلاني من كاربيتوسين
JP2011116764A (ja) *	2011-02-08	2011-06-16	Fine Seymour H	低用量デスモプレシンを含有する医薬組成物
HRP20171092T1 (hr)	2013-06-28	2017-10-06	Amgen Inc.	Stabilna tekuća formulacija amg 416 (velkalcetid)
JP6341777B2 (ja) *	2014-06-30	2018-06-13	リプリーズバイオファーマシューティクス，エルエルシー	低用量デスモプレシンを含有する医薬組成物
KR20170097045A (ko) *	2014-11-20	2017-08-25	알레간 인코포레이티드	알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물
GB201721846D0 (en) *	2017-12-22	2018-02-07	Arecor Ltd	Novel composition
US12156898B2 (en)	2019-05-22	2024-12-03	BIOVIE, Inc.	Formulations of terlipressin
WO2024211393A2 (fr)	2023-04-04	2024-10-10	Tulex Pharmaceuticals Inc.	Compositions orales de desmopressine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61126014A (ja) *	1984-11-22	1986-06-13	Teijin Ltd	経鼻投与用水性液剤
JP2505430B2 (ja) *	1986-11-04	1996-06-12	帝人株式会社	塩基性アミノ酸を含有する経鼻投与用粉末状組成物
EP0432431B1 (fr) *	1989-11-16	1993-06-16	PHIDEA S.p.A.	Composition liquide pharmaceutique pour application nasale contenant un polypeptide comme ingrédient actif
AU653026B2 (en) *	1991-06-07	1994-09-15	Teikoku Seiyaku Kabushiki Kaisha	Physiologically active polypeptide-containing pharmaceutical composition
JPH0640948A (ja) *	1992-07-20	1994-02-15	Kyowa Hakko Kogyo Co Ltd	イオントフォレシス用組成物
JP3628713B2 (ja) *	1993-06-07	2005-03-16	帝國製薬株式会社	生理学的に活性なペプチドを含有する膣投与製剤
US5482931A (en) *	1993-06-29	1996-01-09	Ferring Ab	Stabilized pharmaceutical peptide compositions
US5674850A (en) *	1993-12-23	1997-10-07	Ferring Ab	High purity desmopressin produced in large single batches
AR019727A1 (es) *	1998-06-30	2002-03-13	Takeda Chemical Industries Ltd	Composicion farmaceutica
CA2370520A1 (fr) *	1999-04-16	2000-10-26	Komandoor Elayavalli Achyuthan	Procede de detection de virus utilisant des enzymes codees par des virus et des substrats chimioluminescents
GB0210397D0 (en) *	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
AU2003269747A1 (en) *	2002-05-15	2003-12-02	Sun Pharmaceutical Industries Limited	A stable aqueous composition of a peptide

2000
- 2000-02-16 AT AT0023300A patent/AT409081B/de active
2001
- 2001-01-10 AT AT01901008T patent/ATE253928T1/de active
- 2001-01-10 SI SI200120009A patent/SI21026B/sl not_active IP Right Cessation
- 2001-01-10 US US10/203,614 patent/US20030119728A1/en not_active Abandoned
- 2001-01-10 PL PL01357132A patent/PL357132A1/xx not_active IP Right Cessation
- 2001-01-10 JP JP2001559490A patent/JP2003529562A/ja not_active Ceased
- 2001-01-10 ES ES01901008T patent/ES2210121T3/es not_active Expired - Lifetime
- 2001-01-10 CZ CZ20022686A patent/CZ20022686A3/cs unknown
- 2001-01-10 AU AU26520/01A patent/AU771251B2/en not_active Ceased
- 2001-01-10 PT PT01901008T patent/PT1255557E/pt unknown
- 2001-01-10 TR TR2004/00234T patent/TR200400234T4/xx unknown
- 2001-01-10 CA CA002399822A patent/CA2399822A1/fr not_active Abandoned
- 2001-01-10 DK DK01901008T patent/DK1255557T3/da active
- 2001-01-10 EP EP01901008A patent/EP1255557B1/fr not_active Expired - Lifetime
- 2001-01-10 WO PCT/AT2001/000007 patent/WO2001060394A1/fr not_active Ceased
- 2001-01-10 HU HU0204550A patent/HU229961B1/hu not_active IP Right Cessation
- 2001-01-10 DE DE50100958T patent/DE50100958D1/de not_active Expired - Lifetime
- 2001-01-10 NZ NZ520396A patent/NZ520396A/en unknown
2002
- 2002-01-10 SK SK1049-2002A patent/SK285374B6/sk unknown
- 2002-07-23 ZA ZA200205868A patent/ZA200205868B/en unknown
- 2002-08-15 NO NO20023875A patent/NO20023875L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1255557A1 (fr)	2002-11-13
ATE253928T1 (de)	2003-11-15
TR200400234T4 (tr)	2004-03-22
SI21026B (sl)	2004-02-29
HUP0204550A3 (en)	2004-12-28
ES2210121T3 (es)	2004-07-01
DK1255557T3 (da)	2004-03-22
EP1255557B1 (fr)	2003-11-12
SK10492002A3 (sk)	2003-02-04
ZA200205868B (en)	2004-02-10
WO2001060394A1 (fr)	2001-08-23
HU229961B1 (hu)	2015-03-30
AU2652001A (en)	2001-08-27
HUP0204550A2 (en)	2003-05-28
JP2003529562A (ja)	2003-10-07
SI21026A (sl)	2003-04-30
SK285374B6 (sk)	2006-12-07
AT409081B (de)	2002-05-27
CA2399822A1 (fr)	2001-08-23
CZ20022686A3 (cs)	2003-01-15
ATA2332000A (de)	2001-10-15
US20030119728A1 (en)	2003-06-26
NZ520396A (en)	2004-05-28
AU771251B2 (en)	2004-03-18
NO20023875D0 (no)	2002-08-15
PT1255557E (pt)	2004-04-30
PL357132A1 (en)	2004-07-12
DE50100958D1 (de)	2003-12-18

Publication	Publication Date	Title
NO20023875L (no)	2002-10-11	Stabilt nasalt, oralt eller sublingualt anvendbart preparat
ITBO20050388A1 (it)	2006-12-07	Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ZA200305412B (en)	2004-09-02	4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
TR200302105T4 (tr)	2004-02-23	Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
NO20010531L (no)	2001-01-31	Medisinske aerosolformuleringer
CO5271759A1 (es)	2003-04-30	Formulacion en solucion que contiene una mezcla de disolventes
ATE468845T2 (de)	2010-06-15	Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
MY130441A (en)	2007-06-29	Solutions containing epinastin
DE60120648D1 (de)	2006-07-27	Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
MX2009003030A (es)	2009-05-08	Forma galenita para la administracion por via transmucosa de principios activos.
BRPI0410116A (pt)	2006-05-23	tablete de cuidado oral
ES2171440T3 (es)	2002-09-16	Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
BR0014878A (pt)	2002-06-11	Composição farmacêutica contendo ciclosonida para aplicação à mucosa
ES2052000T3 (es)	1994-07-01	Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
HRP20010764B1 (hr)	2011-01-31	Oralna otopina s prukalopridom
MY136546A (en)	2008-10-31	A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
AR043536A1 (es)	2005-08-03	Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico
ES2159967T3 (es)	2001-10-16	Medicamento que contiene acido delta-aminolevulinico.
TR200102087T2 (tr)	2001-12-21	Yeni morfolinbenzamid tuzları
EP1297838A4 (fr)	2003-07-09	Preparations de gouttes nasales contenant de la pralmoreline
ATE258046T1 (de)	2004-02-15	Pharmazeutische, metamizol enthaltende brauseformulierung
BR0205625C1 (pt)	2004-10-19	Formulações nasais em gel
BG107987A (bg)	2005-02-28	Течна форма на комбинирано лекарствено средство за лечение на простудни и грипни заболявания
MD1898G2 (ro)	2002-10-31	Remediu dermatologic stabilizat pe bază de juglonă

Legal Events

Date	Code	Title	Description
2009-08-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application